Why us?  Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

 Author  Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making. Authored and medically reviewed by Dr Farzana Khan.

MD MRCGP DFFP
Was this answer helpful?
Rate Dr Farzana's explanation

Assessment first
Evidence-aware
Safety focused

Women’s Health Clinic FAQ

Can the O-Shot help with delayed orgasm?

The O-Shot may be relevant when delayed orgasm is linked with reduced sensitivity, dryness, discomfort, low-oestrogen tissue changes, or reduced genital arousal, but delayed orgasm can also be driven by medication, stress, performance pressure, pelvic floor tension, neurological conditions, diabetes, relationship context, or stimulation pattern.

Direct answer

The O-Shot may be relevant when delayed orgasm is linked with reduced sensitivity, dryness, discomfort, low-oestrogen tissue changes, or reduced genital arousal, but delayed orgasm can also be driven by medication, stress, performance pressure, pelvic floor tension, neurological conditions, diabetes, relationship context, or stimulation pattern.

The most useful plan starts with the underlying cause, not the treatment name. Your clinician should review symptoms, medical history, alternatives, expected benefits, limitations and safety.

Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.

Women's Health Clinic consultation for Can the O-Shot help with delayed orgasm?
Consultation-led care

At a glance

These are the main points to understand before deciding whether this option is suitable.

At a glance

Clinical summary

Policy Title

Consent to Examination and Treatment Policy (Version 1).

Lead Authority

Angela Cook (Assistant Director of Quality, Nursing and Allied Health Professionals) and Rhiannon Beaumont-Wood (Executive Director of Quality.

Governance Body

Quality, Safety and Improvement Committee.

Scope

All Wales policy model mandated across Public Health Wales operations.

Important safety note

Statutory Non-Compliance: Non-adherence risks a failure to fulfill the legal mandates of The Health and Social Care (Quality and Engagement) (Wales) Act (2020) regarding the delivery of safe.

Consultation
Suitability
Evidence
Safety
Aftercare




Detailed answer

Detailed answer

The transition from localized PHW protocols to the model developed by the All Wales Consent Group signifies a significant standardization of clinical workflows. Defined Clinical Scope: In a critical refinement for PHW staff, specific chapters of the All Wales policy have been "greyed out" to indicate they are outside the relevant scope of PHW-delivered services.

Clinical context

Defined Clinical Scope: In a critical refinement for PHW staff, specific chapters of the All Wales policy have been "greyed out" to indicate they are outside the relevant.

Mechanism
Evidence
Symptoms
Alternatives

What it means

Defined Clinical Scope: In a critical refinement for PHW staff, specific chapters of the All Wales policy have been "greyed out" to indicate they are outside the relevant.

Why it happens

Procedural Integration: This policy operates in direct conjunction with the "Consent Procedure for Screening Services."

Evidence limits

Information Governance & GDPR: The "Clinical Photography" chapter has been specifically augmented with an Information Governance paragraph to ensure compliance with current GDPR standards.

Treatment fit

Suitability depends on history, symptoms, examination where appropriate and discussion of alternatives.

What this means in practice

Single Point of Truth: Centralized digital hosting on the Public Health Wales Internet site and internal intranet ensures clinicians have immediate access to the latest authorized version.

The procedural chronology for the validation and adoption of this policy was managed through a rigorous governance cycle: Consultation Phase: A formal 28-day statutory consultation window was conducted between December 2022 and January 2023.





Patient safety

Why proper assessment matters

Assessment helps separate marketing claims from safe, individualised clinical decision-making.

It checks the cause

Defined Clinical Scope: In a critical refinement for PHW staff, specific chapters of the All Wales policy have been "greyed out" to indicate they are outside the relevant.

It protects safety

Statutory Non-Compliance: Non-adherence risks a failure to fulfill the legal mandates of The Health and Social Care (Quality and Engagement) (Wales) Act (2020) regarding the delivery of safe.

It reviews alternatives

Single Point of Truth: Centralized digital hosting on the Public Health Wales Internet site and internal intranet ensures clinicians have immediate access to the latest authorized version.

It sets expectations

Consultation Phase: A formal 28-day statutory consultation window was conducted between December 2022 and January 2023.

A clinical decision, not a shortcut

The safest final page should explain what the intervention may do, what it cannot promise, and when another route may be better.

Treatment should be discussed with realistic goals, informed consent, clear aftercare and a plan for review.





Considerations

What to consider

Single Point of Truth: Centralized digital hosting on the Public Health Wales Internet site and internal intranet ensures clinicians have immediate access to the latest authorized version.

Consultation priorities

Person-Centred Care: Enshrines the "person-centred" mandate of the 2020 Act as a clinical reality.

History
Consent
Aftercare
Follow-up

Before treatment

Person-Centred Care: Enshrines the "person-centred" mandate of the 2020 Act as a clinical reality.

During care

Systemic Safety: Eliminates procedural variance, thereby improving patient safety and confidence as they navigate different clinical settings.

Aftercare

Linguistic Rights: Reinforces the commitment to bilingual service provision, ensuring Welsh-speaking patients receive equitable access to policy information.

When to reassess

If expected improvement does not occur, the plan should be reviewed rather than repeated automatically.

Practical expectations

Consultation Phase: A formal 28-day statutory consultation window was conducted between December 2022 and January 2023.

Multidisciplinary Dissemination: Policy awareness is driven through the Nursing Synedd (Nursing Senedd/Council), the Safeguarding Group, and specialized leadership including the Director of Screening Division, the Head of Nursing.





Common concerns and myths

Common misconceptions

Clear patient information should correct over-simple claims and keep expectations realistic.

Myth: Delayed orgasm is always caused by low sensitivity.

Reality: suitability depends on the symptom pattern, medical history, contraindications, alternatives and individual goals.

Myth: The O-Shot should make orgasm instant.

Reality: results vary, evidence may be developing, and non-response should prompt reassessment.

Myth: Taking longer to orgasm is always abnormal.

Reality: injections, devices and intimate procedures can still carry risks and need proper consent and aftercare.

Evidence and advertising

Procedural Integration: This policy operates in direct conjunction with the "Consent Procedure for Screening Services."

Alternatives

Single Point of Truth: Centralized digital hosting on the Public Health Wales Internet site and internal intranet ensures clinicians have immediate access to the latest authorized version.





Safety checklist

Safety checklist

Use these questions to decide whether treatment should be discussed, delayed or redirected.

Has the cause been assessed?

Symptoms should be reviewed in context before selecting a treatment.

Are red flags absent?

Statutory Non-Compliance: Non-adherence risks a failure to fulfill the legal mandates of The Health and Social Care (Quality and Engagement) (Wales) Act (2020) regarding the delivery of safe.

Are alternatives clear?

Single Point of Truth: Centralized digital hosting on the Public Health Wales Internet site and internal intranet ensures clinicians have immediate access to the latest authorized version.

Is follow-up planned?

The clinic should explain aftercare, review timing and when to seek help.

Reassuring signs

Proceeding is more reasonable when goals are clear, red flags have been checked, and expectations are realistic.

Clear goals
No red flags
Follow-up plan

Reasons to pause

Statutory Non-Compliance: Non-adherence risks a failure to fulfill the legal mandates of The Health and Social Care (Quality and Engagement) (Wales) Act (2020) regarding the delivery of safe.

Pain
Bleeding
Infection




When to escalate

When to seek medical help

Some symptoms should be assessed before any elective intimate treatment. Use NHS 111 online

Severe or worsening pain

Statutory Non-Compliance: Non-adherence risks a failure to fulfill the legal mandates of The Health and Social Care (Quality and Engagement) (Wales) Act (2020) regarding the delivery of safe.

Bleeding or discharge

Mitigation of Corporate Risk: This risk is formally identified and monitored via the Corporate Risk Register, Entry 207.

Infection signs

Quality Standard Imperatives: This policy is a primary mechanism for upholding the Health and Care Standards for NHS Wales, specifically focusing on:

Emergency symptoms

Call 999 in a life-threatening emergency, including collapse, chest pain or breathing difficulty.

Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.

More clinical detail

Benchmark positioning

  • The page should win by mapping delayed orgasm precisely and avoiding the simplistic competitor assumption that more sensation automatically solves timing.

Clinical reality

  • Defined Clinical Scope: In a critical refinement for PHW staff, specific chapters of the All Wales policy have been "greyed out" to indicate they are outside the relevant scope of PHW-delivered services.
  • Procedural Integration: This policy operates in direct conjunction with the "Consent Procedure for Screening Services."
  • Information Governance & GDPR: The "Clinical Photography" chapter has been specifically augmented with an Information Governance paragraph to ensure compliance with current GDPR standards.

Timeline and expectations

  • Consultation Phase: A formal 28-day statutory consultation window was conducted between December 2022 and January 2023.
  • Leadership Approval: The PHW Leadership Team formally endorsed the accompanying Procedure on January 27, 2023.
  • Committee Approval: The Quality, Safety and Improvement Committee ratified the overarching Policy during its session on February 15, 2023.
  • Implementation/Dissemination: Organizational dissemination and full adoption were initiated in February 2023.

Practical logistics

  • Single Point of Truth: Centralized digital hosting on the Public Health Wales Internet site and internal intranet ensures clinicians have immediate access to the latest authorized version.
  • Multidisciplinary Dissemination: Policy awareness is driven through the Nursing Synedd (Nursing Senedd/Council), the Safeguarding Group, and specialized leadership including the Director of Screening Division, the Head of Nursing Screen Division, and the Named Lead.
  • Bilingual Mandate: To meet statutory obligations, the policy is provided in both Welsh and English.
  • Resource Requirements: Any implementation requiring additional training or localized resources must be managed through a formal "Implementation Plan" using the organization's standard template.

Research sources

  • The Health and Social Care (Quality and Engagement) (Wales) Act (2020).
  • Health and Care Standards for NHS Wales (Quality Themes 2, 3, and 6).
  • Public Health Wales Corporate Risk Register, Entry 207.
  • All Wales Consent Policy (Model Policy), Welsh Risk Pool.

Next step

Book a clinical consultation

A consultation can confirm whether this treatment may be suitable, whether another pathway should come first, and what realistic outcomes and aftercare would look like.

View Full Research Bibliography (10 Sources)
• AIG Aesthetic Care - Inspection report - CQC
• Efficacy and Safety of Platelet-Rich Plasma Injections for the Treatment of Female Sexual Dysfunction and Stress Urinary Incontinence: A Systematic Review - PMC
• Evaluating Clinical Trials using Platelet-Rich Plasma to Treat Female Sexual Dysfunction
• Low sex drive (loss of libido) - NHS
• Platelet-rich plasma in the management of vulvovaginal disorders: a systematic review
• Policy / Procedure Approval Report Name of Meeting Quality, Safety and Improvement Committee Date of Meeting 15 February 2023 A - Public Health Wales
• Vaginal Injection of Platelet-Rich Plasma for Sexual Function: A Randomized Controlled Trial - PubMed
• Value of Injection of Plasma-Rich Platelets in the vaginal and the clitoris in cases with female sexual dysfunction - Ginekologia i Poloznictwo
• What is the O-Shot and how does it work with laser treatment? - The Womens Health Clinic
• https://www.imperial.nhs.uk/~/media/website/gps-and-referrers/gp-documents/gp-professional-development/sexual-health-june-2018/female-sexual-function-dr-ali-mears.pdf

Educational only. This document serves as a high-level summary of the approved Public Health Wales Consent Policy. Clinical staff must consult the full 'Consent to Examination and Treatment Policy (Version 1)' and associated local procedures on the PHW intranet to ensure full compliance with legal and professional standards before seeking patient consent. Results vary. Not a cure.

Loading directory...